{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:58:41Z","timestamp":1772755121367,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Hepatoblastoma (HB) is the most common liver malignancy in children. The prognosis changes according to the histologic subtypes of HB. In the present study, we aimed to characterize the expression level of selected microRNAs (miRNAs) in HB as well as in histologic subtypes, and to consider the association with the prognosis. A total of 22 HB tumor samples, subtyped as fetal (n=16) and embryonal (n=6), and 10 nontumorous surrounding liver samples were evaluated in this study. Expressions of miR-17, miR-146a, miR-302d, and miR-19b were analyzed in 22 HB tumor samples and 10 nontumorous surrounding liver samples by quantitative real-time polymerase chain reaction. Lower miRNA-17 expression levels were obtained in tumor samples in comparison with nontumorous surrounding liver samples (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.028). Lower miRNA-17 expression was significant for predicting prognosis in HB patients (area under receiver-operator characteristic curve=0.875, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.044). A higher-level of miR-19b was found in embryonal samples (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.008). Overall and event-free survival was not found to correlate with miRNA expression levels (<jats:italic toggle=\"yes\">P<\/jats:italic>&gt;0.05). This research finds miRNA-17 and miRNA-19b expression levels can provide important data on diagnosis and prognosis in HB showing different clinical behaviors.<\/jats:p>","DOI":"10.1097\/mph.0000000000001234","type":"journal-article","created":{"date-parts":[[2018,6,10]],"date-time":"2018-06-10T15:33:08Z","timestamp":1528644788000},"page":"7-12","source":"Crossref","is-referenced-by-count":17,"title":["MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance"],"prefix":"10.1097","volume":"41","author":[{"given":"\u00c7i\u011fdem \u00d6.","family":"Ecevit","sequence":"first","affiliation":[{"name":"Pediatric Gastroenterology, Hepatology, and Nutrition"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safiye","family":"Akta\u015f","sequence":"additional","affiliation":[{"name":"Department of Basic Oncology, Dokuz Eyl\u00fcl University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fclya","family":"Tosun Yildirim","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beng\u00fc","family":"Demira\u011f","sequence":"additional","affiliation":[{"name":"Pediatric Oncology, Dr. Beh\u00e7et Uz Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe","family":"Erbay","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Adana Ba\u015fkent University, Ankara"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130rfan","family":"Karaca","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, \u0130zmir Medical Park Hospital, Winston-salem, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"\u00c7elik","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Ege University, Bornova, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe Banu","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, \u0130zmir University of Economics, Izmir"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe Pinar","family":"Er\u00e7etin","sequence":"additional","affiliation":[{"name":"Department of Basic Oncology, Dokuz Eyl\u00fcl University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur","family":"Olgun","sequence":"additional","affiliation":[{"name":"Department of Basic Oncology, Dokuz Eyl\u00fcl University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1634\/theoncologist.5-6-445","article-title":"Childhood cancer: Hepatoblastoma","volume":"5","author":"Herzog","year":"2000","journal-title":"The Oncologist"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/hpb.12112","article-title":"Predictors of survival and incidence of hepatoblastoma in the paediatric population","volume":"15","author":"Allan","year":"2013","journal-title":"HPB"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0022-3476(05)80297-5","article-title":"Risk of hepatoblastoma in familial adenomatous polyposis","volume":"119","author":"Giardiello","year":"1991","journal-title":"J Pediatr"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.bjc.6604335","article-title":"Perinatal risk factors for hepatoblastoma","volume":"98","author":"Spector","year":"2008","journal-title":"Br J Cancer"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1200\/JCO.2010.29.3837","article-title":"Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children\u2019s Oncology Group","volume":"29","author":"Malogolowkin","year":"2011","journal-title":"J Clin Oncol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.2005.07.145","article-title":"Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the international society of pediatric oncology liver tumor study group SIOPEL-1 study","volume":"23","author":"Aronson","year":"2005","journal-title":"J Clin Oncol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.humpath.2008.10.022","article-title":"Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways","volume":"40","author":"Adesina","year":"2009","journal-title":"Hum Pathol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.humpath.2005.12.015","article-title":"Claudin-1 and claudin-2 differentiate fetal and embriyonal components in human hepatoblastoma","volume":"37","author":"Halasz","year":"2006","journal-title":"Hum Pathol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s003830000576","article-title":"High frequency of beta-catenin mutations in hepatoblastoma","volume":"17","author":"Udatsu","year":"2001","journal-title":"Pediatr Surg Int"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","article-title":"Outcome of hepatoblastoma treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT","volume":"27","author":"Hishiki","year":"2011","journal-title":"Pediatr Surg Int"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.4161\/cc.7.16.6453","article-title":"MicroRNAs and cancer: an overview","volume":"7","author":"Medina","year":"2008","journal-title":"Cell Cycle"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4161\/cc.7.16.6452","article-title":"Functional integration of microRNAs into oncogenic and tumor suppressor pathways","volume":"7","author":"Lotterman","year":"2008","journal-title":"Cell Cycle"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.24125","article-title":"MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma","volume":"53","author":"von Frowein","year":"2011","journal-title":"Hepatology"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00428-014-1549-y","article-title":"MicroRNA expression might predict prognosis of epithelial hepatoblastoma","volume":"464","author":"Gyugos","year":"2014","journal-title":"Virchows Arch"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00383-016-3960-8","article-title":"Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study","volume":"32","author":"Liu","year":"2016","journal-title":"Pediatr Surg Int"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13742-015-0099-9","article-title":"Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples","volume":"4","author":"Leichter","year":"2015","journal-title":"Giga Science"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1038\/srep10438","article-title":"A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patients","volume":"5","author":"Chatterjee","year":"2015","journal-title":"Scientific reports"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ejso.2014.07.033","article-title":"Predictors of survival after resection of children with hepatoblastoma: a single Asian center experience","volume":"40","author":"Qiao","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-015-0162-0","article-title":"MiRNA-based therapeutic intervention of cancer","volume":"8","author":"Naidu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"MicroRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev Biol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(12)70073-6","article-title":"microRNAs in cancer management","volume":"13","author":"Kong","year":"2012","journal-title":"Lancet Oncol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"99516","DOI":"10.1371\/journal.pone.0084311","article-title":"The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195\/497 cluster","volume":"9","author":"Itesako","year":"2014","journal-title":"PLoS One"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"53906","DOI":"10.1371\/journal.pone.0053906","article-title":"MicroRNA-221 induces cell survival and cisplatin resistance through PI3K\/Akt pathway in human osteosarcoma","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1158\/0008-5472.CAN-06-0800","article-title":"MicroRNA-cancer connection: the beginning of a new tale","volume":"66","author":"Calin","year":"2006","journal-title":"Cancer Res"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1261\/rna.1162708","article-title":"Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell like state","volume":"14","author":"Lin","year":"2008","journal-title":"RNA"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-09-3301","article-title":"Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets","volume":"70","author":"Palmer","year":"2010","journal-title":"Cancer Res"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1158\/0008-5472.CAN-10-2746","article-title":"MikroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4\/6 cell cycle pathways","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res"},{"key":"R33-20230918","first-page":"124240","article-title":"MicroRNA-302a suppresses tumor cell proliferation by inhibiting AKT in prostate cancer","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","article-title":"MicroRNA-146a: a dominant, negative regulator of the innate immune response","volume":"5","author":"Saba","year":"2014","journal-title":"Front Immunol"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","article-title":"miR-146a suppresses invasion of pancreatic cancer cells","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"key":"R36-20230918","first-page":"2502","article-title":"MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6","volume":"6","author":"Zu","year":"2016","journal-title":"Am J Cancer Res"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/cam4.775","article-title":"MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics","volume":"5","author":"Shea","year":"2016","journal-title":"Cancer Medicine"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1002\/dvdy.20956","article-title":"MicroRNA expression during chick embryo development","volume":"235","author":"Darnell","year":"2006","journal-title":"Dev Dyn"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yjmcc.2014.06.017","article-title":"MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor","volume":"75","author":"Li","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2014.07.005","article-title":"MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1","volume":"236","author":"Lv","year":"2014","journal-title":"Atherosclerosis"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2011.12.032","article-title":"MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells","volume":"417","author":"Yin","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11010-013-1679-6","article-title":"MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion","volume":"380","author":"Yu","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1671-5","article-title":"Upregulation of microRNA-19b predicts goog prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease","volume":"15","author":"Hung","year":"2015","journal-title":"BMC Cancer"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2012.02.038","article-title":"MicroRNA-19a and -19b regulate servical carcinoma cell proliferation and invasion by targeting CUL5","volume":"322","author":"Xu","year":"2012","journal-title":"Cancer Lett"},{"key":"R45-20230918","first-page":"4220","article-title":"MiR-19b\/20a\/92a regulates the self-renewal and proliferation of gastric cancer stem cells","volume":"126","author":"Wu","year":"2013","journal-title":"J Cell Sci"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10549-014-3040-5","article-title":"Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer","volume":"146","author":"Fan","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"531","DOI":"10.18632\/oncoscience.69","article-title":"MicroRNA-17 inhibits tumor growth by stimulating T-cell mediated host immune responce","volume":"1","author":"Li","year":"2014","journal-title":"Oncoscience"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"46367","DOI":"10.1371\/journal.pone.0046367","article-title":"Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma","volume":"7","author":"Zeng","year":"2012","journal-title":"PLoS One"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.jpedsurg.2011.09.003","article-title":"Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability","volume":"46","author":"Ueda","year":"2011","journal-title":"J Pediatr Surg"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1158\/0008-5472.CAN-13-0927","article-title":"Silencing of the miR-17\u223c92 cluster family inhibits medulloblastoma progression","volume":"73","author":"Murphy","year":"2013","journal-title":"Cancer Res"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbrc.2013.04.003","article-title":"Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern","volume":"434","author":"El Tayebi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/08941939.2011.618523","article-title":"Mir-17-5p as a novel prognostic marker for hepatocellular carcinoma","volume":"25","author":"Chen","year":"2012","journal-title":"J Invest Surg"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201901000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:41:43Z","timestamp":1695012103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201901000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001234","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}